Mesoblast could need another COVID trial says CEO
MELBOURNE: Losses at stem cell treatments producer Mesoblast have hit $US98.8 million ($135 million) for
MELBOURNE: Losses at stem cell treatments producer Mesoblast have hit $US98.8 million ($135 million) for
FEATURED
Major investor makes its first move into Senior Housing
Blood test may revolutionise how signs of Alzheimer’s are spotted
Virtual care centre reveals new images and plan for innovation hub
Intergenerational housing for seniors and young adults to be built
Seniors group applies for housing grant to build innovative project
Nursing home plans approved for site of elderly housing
INNOVATION
